Investigation of the efficacy of the short regimen for rifampicin-resistant TB from the STREAM trial

Investigation of the efficacy of the short regimen for rifampicin-resistant TB from the STREAM trial

Abstract Background The STREAM trial demonstrated that a 9–11-month “short” regimen had non-inferior efficacy and comparable safety to a 20+ month “long” regimen for the treatment of rifampicin-resistant tuberculosis. Imbalance in the components of the composite primary outcome merited further inves...

Full description

Bibliographic Details
Main Authors: P. P. J. Phillips, A. Van Deun, S. Ahmed, R. L. Goodall, S. K. Meredith, F. Conradie, C-Y Chiang, I. D. Rusen, A. J. Nunn
Format: Article
Language:English
Published: BMC 2020-11-01
Series:BMC Medicine
Subjects:
MDR-TB
Tuberculosis
Short regimen
Non-inferiority
Causal inference
Inverse probability of censoring weighting
Online Access:http://link.springer.com/article/10.1186/s12916-020-01770-z

Internet

http://link.springer.com/article/10.1186/s12916-020-01770-z

Similar Items